Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 10, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Regeneron Pharmaceuticals,...
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 05, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Regeneron Pharmaceuticals,...
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 03, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Regeneron Pharmaceuticals, Inc....
-
SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired Regeneron Pharmaceuticals, Inc. (NASDAQ:...
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, July 10, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Regeneron Pharmaceuticals,...
-
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 30, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Regeneron Pharmaceuticals,...